Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 28, 2005; 11(8): 1141-1148
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1141
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1141
Group | 4 wk | 8wk | 12 wk | |||
Grade1 | Lesion | Grade | Lesion | Grade | Lesion | |
CCl4 | 2 | Mild fibrosis | 3 | Severe fibrosis | 4 | Cirrhosis |
CCl4+Sily | 0-1 | Mild fatty change | 1-2 | Mild fatty change and fibrosis | 2-3 | Severe fatty change and fibrosis |
- Citation: Jeong DH, Lee GP, Jeong WI, Do SH, Yang HJ, Yuan DW, Park HY, Kim KJ, Jeong KS. Alterations of mast cells and TGF-β1 on the silymarin treatment for CCl4-induced hepatic fibrosis. World J Gastroenterol 2005; 11(8): 1141-1148
- URL: https://www.wjgnet.com/1007-9327/full/v11/i8/1141.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i8.1141